FounderNest™

Start exploring your own markets for free

🚀 Try for Free

/AI Therapeutics

Invite

Pending to review

Not sure yet

Interested

Not interested

Download list

Company	Fit assessment	Description	Subspaces	Tags	HQ Location	Founding Date	Employees	Total Funding Raised	Last Funding Event	Received on
Vium	Vium leverages machine learning to discover patterns and identify biomarkers, facilitating the advancement of new therapeutics in preclinical research.	Vium is a biotechnology company that develops digital biomarkers to transform preclinical research and animal welfare. It is fully accredited by AAALAC International and received an unprecedented AAALAC commendation for upholding the 3 Rs, the gold-standard framework for humane animal research. Customers run the spectrum of biotechnology, pharmaceutical, and computational drug discovery companies to academia and novel therapeutic labs. Vium's digital platform provides physiological biomarkers that enable better decisions on which compounds should be advanced to the clinic. The company's platform Digital Vivariumand Vium Cloud is the gold-standard in vivo platform combining computer vision, artificial intelligence, machine learning, and sensor technology to non-invasively collect and derive insights from digital biomarkers. The platform continuously captures physiological metrics and behaviors non-invasively, providing more sensitive and accurate data collection, leading to more replicable studies. Vium was founded in 2013 and is headquartered in San Mateo, California, United States.	Biomarker Identification	Light Search	San Mateo (United States)	2013	51 - 200	$53.94M	Acquired by Recursion Pharmaceuticals, July 2020	Oct 14, 2024
USC Big Data Health Science Center	The USC Big Data Health Science Center leverages machine learning for innovative research, discovering patterns and expanding therapeutic approaches, while also focusing on biomarker identification.	The University of South Carolina (USC) Big Data Health Science Center (BDHSC), an interdisciplinary enterprise and one of the USC Excellence Initiatives established in 2019, promotes and supports big data health science research through capacity development, academic training, professional development, community engagement, and methodological advancement. Its five content cores (Artificial Intelligence for Sensing and Diagnosis, Electronic Health Records, Genomics, Geospatial, and Social Media) and two functional hubs (Business/Entrepreneurship and Technology) embody interdisciplinary collaboration and foster cutting-edge research and discovery. Our mission is to be an innovation-driven enterprise that can facilitate and accelerate a sustained, high-caliber transformation of the USC into a global leader in big data health science.	Biomarker Identification	Light Search	United States		11 - 50		NA	Oct 14, 2024
MNM Bioscience Inc.	MNM leverages machine learning for pattern discovery and the development of new therapeutics, while also focusing on biomarker identification to enhance personalized medicine.	MNM is a scientific start-up created by an interdisciplinary group of enthusiasts. We are a multi-specialist team of experts from geneticists, to molecular biologists, bioinformaticians and AI specialists. We combine next-generation AI with the most advanced genomic approaches (whole genome and multiomics data) to save the lives of cancer patients through predictive modeling and drug target identification.	Biomarker Identification	Light Search	Cambridge (United States)	2018	33	$3.29M	Seed, $2.44M, October 20, 2020	Oct 14, 2024
Bioada	Bioada leverages machine learning for pattern discovery and aims to expand therapeutics through innovative biomarker and drug discovery solutions.	Developer of AI-powered biomarker and drug discovery solutions designed to revolutionize EMR software and unlock new frontiers in biomarker and drug discovery. The company offers AI-powered biomarker and drug discovery solutions, enabling customers to make breakthroughs in biomarker and drug discovery that were once thought to be impossible.	Biomarker Identification	Light Search	Toronto (Canada)	2021	1 - 10		NA	Oct 14, 2024
Intelligent OMICS	Intelligent OMICS leverages machine learning to discover patterns and expand therapeutic options, while also identifying biomarkers for personalized medicine.	Intelligent OMICS is a translational company that converts big data into biological intelligence.	Biomarker Identification	Light Search	Nottingham (United Kingdom)	2009	1 - 10		NA	Oct 14, 2024
OntoChem	OntoChem leverages machine learning and pattern discovery to enhance therapeutic development and identify biomarkers, showcasing their innovative approach in the life sciences.	Developer of tools and algorithms designed to provide added value to customers by helping them to navigate the complex information world. The company's tools and algorithms develop individual or industrial-scale cognitive computing solutions to perform customized indexing of intranet and internet data, enabling clients to apply semantic search solutions for pharmaceutical, material sciences, and technology-driven businesses.	Biomarker Identification	Light Search	Germany	2005	11 - 50		Acquired by Digital Science, June 2023	Oct 14, 2024
Pheiron	Pheiron leverages machine learning to discover patterns and develop targeted therapeutics, while also focusing on biomarker identification for personalized medicine.	Pheiron provides a scalable, secure, and interoperable platform for deep data-driven health management. The company focuses on improving the probability of success in drug development by leveraging causal insights on targets and populations. Pheiron uses AI to map multimodal data to diseases, aiming to enhance the understanding of diseases and inform decision-making in drug development. The platform also supports large-scale exome sequence analysis to identify sex- and age-specific factors in health management.	Biomarker Identification	Light Search	Berlin (Germany)	2023	1 - 10		NA	Oct 14, 2024
IMVARIA	IMVARIA leverages machine learning to enhance patient outcomes through novel pattern discovery and the expansion of therapeutics, focusing on digital biomarker identification.	IMVARIA is advancing noninvasive AI biomarkers for better patient lives. We bring artificial intelligence to imaging and lab data, re-imagining clinical assessments in serious diseases. IMVARIA serves Fibresolve -- the first AI diagnostic tool in interstitial lung disease (ILD) and idiopathic pulmonary fibrosis (IPF). Fibresolve is an FDA Breakthrough Device and is authorized by the FDA to serve as an adjunctive, non-invasive diagnostic tool for patients with suspected ILD and IPF. Beyond ILD and IPF, IMVARIA is developing AI biomarkers in multiple areas including oncology, pulmonology, immunology, and more.	Biomarker Identification	Light Search	Berkeley (United States)	2019	11 - 50		Seed, April 30, 2020	Oct 14, 2024
Promise Bio	The company effectively leverages machine learning for biomarker discovery and therapeutic expansion, demonstrating a strong fit in the healthcare innovation space.	Promise Bio is focused on pioneering precision medicine by utilizing epiproteomic analysis to understand autoimmune diseases. The company employs a cloud-based AI platform to perform comprehensive analyses of standard mass-spectrometry data, revealing insights into protein modifications that affect disease mechanisms.	Biomarker Identification	Light Search	Tel Aviv-Yafo (Israel)	2023	1 - 10	$8.30M	Grant, December 16, 2024	Oct 14, 2024
Talon Biomarkers	Talon Biomarkers leverages machine learning for data analysis, discovers patterns in immune cell responses, and enhances therapeutic strategies through biomarker identification.	Developer of a biomarker discovery engine designed for precision medicine and immunotherapy success. The company's services include consultation and support, data analytics, immune profiling, and biomarker discovery services, thereby providing comprehensive immune analysis services and delivering insights that advance understanding and transform patient care.	Biomarker Identification	Light Search	Hanover (United States)	2021	1 - 10		NA	Oct 14, 2024

Use "Get more companies" to continue searching, or run a “Deep Dive” for a comprehensive mapping